Propeller Health, Novartis ink collaboration for connected inhaler

Propeller Health said today that it landed a collaborative agreement with Novartis (NYSE:NVS) to develop a custom add-on sensor for the Breezhaler inhaler. The partnership is focused on patients with chronic obstructive pulmonary disease in Europe. The Breezhaler is a capsule-based, dry powder inhaler and is a part of Novartis’ portfolio of COPD therapies. The custom sensors developed as a result of this collaboration will passively record and transmit compliance data, according to Propeller, which will better inform patients and physicians of adherence. Get the full story at our sister site, Drug Delivery Business News.  The post Propeller Health, Novartis ink collaboration for connected inhaler appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Drug-Device Combinations Research & Development Respiratory Wall Street Beat Novartis AG Propeller Health Source Type: news